4.6 Review

Hadrontherapy for Thymic Epithelial Tumors: Implementation in Clinical Practice

Related references

Note: Only part of the references are listed.
Article Oncology

Improving outcomes of surgery in advanced infiltrative thymic tumours: the benefits of multidisciplinary approach

Andrea Bille et al.

Summary: Surgery for stage III and IVa thymoma is safe and effective, with complete macroscopic resection achieved in the majority of patients. Combined surgical approaches can be used to obtain adequate exposure with no increased morbidity, and postoperative outcomes are generally positive, with few complications and low recurrence rates.

TUMORI JOURNAL (2022)

Article Radiology, Nuclear Medicine & Medical Imaging

FDG PET correlates weakly with HIF-1α expression in solid tumors: a meta-analysis

Alexey Surov et al.

Summary: The study aimed to provide clear data about the associations between maximum standardized uptake value (SUVmax) and HIF-1 alpha expression in solid tumors. The results showed a weak correlation between SUVmax of FDG PET and HIF-1 alpha in both overall sample and tumor subgroups.

ACTA RADIOLOGICA (2021)

Article Oncology

Safety Margins for the Delineation of the Left Anterior Descending Artery in Patients Treated for Breast Cancer

Eliot Nicolas et al.

Summary: The study aimed to establish a safety margin for delineation of the LAD in BC patients by studying 45 patients with left-sided BC and determining the LAD diameter and movements. It was suggested to use a cylinder with a diameter of 10 mm surrounding the LAD as the safety delineation margin. These findings need to be validated in independent series of patients treated for BC.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2021)

Letter Cardiac & Cardiovascular Systems

First-in-man case of non-invasive proton radiotherapy for the treatment of refractory ventricular tachycardia in advanced heart failure

Veronica. Dusi et al.

EUROPEAN JOURNAL OF HEART FAILURE (2021)

Article Oncology

The safety and efficacy of Cyberknife® for thymic malignancy

C. Xu et al.

Summary: The study aimed to evaluate the safety and efficacy of Cyberknife for primary or recurring thymic tumors. Out of 12 patients, 41.7% received CK initially for inoperable disease or refusal of surgery, while 58.3% received CK upon recurrence. CK treatment showed high response rates with good local control and minimal side effects, suggesting potential for combining CK with immunotherapy. Larger sample studies are needed for further validation.

CANCER RADIOTHERAPIE (2021)

Article Oncology

Clinical practice of breast cancer protontherapy: A single-centre experience from selection to treatment

P. Loap et al.

Summary: Despite the dosimetric advantages and excellent clinical tolerance, the lack of availability of protontherapy machines currently limits the wider implementation of breast protontherapy.

CANCER RADIOTHERAPIE (2021)

Article Oncology

Differential Immune Modulation With Carbon-Ion Versus Photon Therapy

Catherine S. Spina et al.

Summary: The study compared the immunomodulatory effects of carbon-ion therapy (CiRT) with biologically equivalent doses of photon therapy (PhRT) on solid tumors. Results showed that CiRT had different effects on lymphocytes compared to PhRT, with CiRT generally being lymphocyte-sparing at low doses and a more potent inducer of proinflammatory cytokines at high doses. This indicates that CiRT may be a potential modulator of the immunologic characteristics of the tumor microenvironment.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

An MRI framework for respiratory motion modelling validation

Giorgia Meschini et al.

Summary: This study proposed a validation framework for respiratory motion models based on MRI, using repeated MRI data from patients to evaluate model performance. Results showed that the model performance depended on the deformable image registration (DIR) error, with reduced accuracy in the presence of inter-fraction baseline variations.

JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY (2021)

Article Oncology

Clinical and technical considerations for mediastinal Hodgkin lymphoma protontherapy based on a single-center early experience

P. Loap et al.

Summary: This study analyzed the practice of mediastinal Hodgkin lymphoma protontherapy at Institut Curie in France. Among 20 screened patients, four ultimately received proton beam treatment with good clinical outcomes.

CANCER RADIOTHERAPIE (2021)

Article Oncology

Proton Beam Therapy for Thymic Carcinoma with Pericardial Involvement

Pierre Loap et al.

Summary: This study reported the first case of definitive proton beam therapy for advanced thymic carcinoma with pericardial invasion. The results showed that compared to volumetric modulated arc therapy, proton beam therapy reduced doses to critical organs such as the heart, lungs, and esophagus.

INTERNATIONAL JOURNAL OF PARTICLE THERAPY (2021)

Review Radiology, Nuclear Medicine & Medical Imaging

Harnessing radiation to improve immunotherapy: better with particles?

Marco Durante et al.

BRITISH JOURNAL OF RADIOLOGY (2020)

Article Oncology

Volumetric modulated arc therapy versus intensity-modulated proton therapy in the postoperative irradiation of thymoma

Davide Franceschini et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2020)

Review Oncology

Carbon Ion Radiobiology

Walter Tinganelli et al.

CANCERS (2020)

Review Respiratory System

Immunotherapy for thymoma

Marko Jakopovic et al.

JOURNAL OF THORACIC DISEASE (2020)

Article Radiology, Nuclear Medicine & Medical Imaging

An in silico planning study comparing doses and estimated risk of toxicity in 3D-CRT, IMRT and proton beam therapy of patients with thymic tumours

Anders Lidestahl et al.

PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS (2019)

Article Radiology, Nuclear Medicine & Medical Imaging

Implementation of proton therapy treatments with pencil beam scanning of targets with limited intrafraction motion

Francesco Fracchiolla et al.

PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS (2019)

Article Oncology

A Comparison of Grade 4 Lymphopenia With Proton Versus Photon Radiation Therapy for Esophageal Cancer

David M. Routman et al.

ADVANCES IN RADIATION ONCOLOGY (2019)

Article Oncology

Rationale and early outcomes for the management of thymoma with proton therapy

He J. Zhu et al.

TRANSLATIONAL LUNG CANCER RESEARCH (2018)

Article Oncology

Predicted Rate of Secondary Malignancies Following Adjuvant Proton Versus Photon Radiation Therapy for Thymoma

J. Vogel et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)

Article Oncology

Radiation Dose-Response Relationship for Risk of Coronary Heart Disease in Survivors of Hodgkin Lymphoma

Frederika A. van Nimwegen et al.

JOURNAL OF CLINICAL ONCOLOGY (2016)

Article Oncology

Alterations of the Immune System in Thymic Malignancies

Benny Weksler et al.

JOURNAL OF THORACIC ONCOLOGY (2014)

Article Oncology

Postoperative Proton Therapy in the Management of Stage III Thymoma

Nicolas Figura et al.

JOURNAL OF THORACIC ONCOLOGY (2013)

Article Medicine, General & Internal

Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer

Sarah C. Darby et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Meeting Abstract Oncology

Adjuvant Radiotherapy (RT) for Thymoma: A Dosimetric Comparison of Photon and Proton Based Treatment Techniques

S. D. Swisher-McClure et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)

Article Mathematical & Computational Biology

Site-specific dose-response relationships for cancer induction from the combined Japanese A-bomb and Hodgkin cohorts for doses relevant to radiotherapy

Uwe Schneider et al.

THEORETICAL BIOLOGY AND MEDICAL MODELLING (2011)

Article Radiology, Nuclear Medicine & Medical Imaging

18F-FDG PET/CT is Useful for Pretreatment Assessment of the Histopathologic Type of Thymic Epithelial Tumors

Ji Young Kim et al.

NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)

Review Oncology

Number of patients potentially eligible for proton therapy

B Glimelius et al.

ACTA ONCOLOGICA (2005)